Literature DB >> 22840610

The relevance of oxidative stress status in first episode and recurrent depression.

Cristinel Stefanescu1, Alin Ciobica.   

Abstract

Oxidative and nitrosative stress (O&NS) could play an important role in the pathophysiology of major depression (MDD). The aim of the present work was to evaluate the specific activity of the main peripheral antioxidant defences (superoxide dismutase--SOD and glutathione peroxidase--GPX) and the level of malondialdehyde--MDA (a lipid peroxidation maker), in depressed patients, as compared to an age-matched control group. Also, we were interested to see if there are any differences between first episode vs. recurrent depression groups, in terms of oxidative stress markers. Additionally, we want it to investigate the effects of different antidepressant medication (mirtazapine, venlafaxine, tianeptine and escitalopram) on oxidative status of depressed patients. Our results showed an increased oxidative stress status in the serum of patients with MDD, expressed by a significant decrease of both SOD and GPX specific activities and a significant increase of the lipid peroxidation marker MDA, as compared to the control group. When we analyzed the oxidative stress status in depressed patients based on chronicity we observed significant decrease of SOD and GPX specific activities in recurrent depression group, as compared to the first episode group. Moreover, a very significant increase in MDA concentration was observed in recurrent depression patients, as compared to the first episode group. Our work provides additional evidences of increased oxidative stress in MDD, expressed by altered antioxidant enzyme activity and increased levels of lipid peroxidation. Also, it seems that sub-classifying depression into different subtypes, based on chronicity, can predict differences in the levels of some various oxidative stress markers.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22840610     DOI: 10.1016/j.jad.2012.05.022

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  51 in total

Review 1.  Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications.

Authors:  George Anderson; Michael Berk; Olivia Dean; Steven Moylan; Michael Maes
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

Review 2.  The glutathione system: a new drug target in neuroimmune disorders.

Authors:  Gerwyn Morris; George Anderson; Olivia Dean; Michael Berk; Piotr Galecki; Marta Martin-Subero; Michael Maes
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

Review 3.  Molecular Mechanisms Underlying the Anti-depressant Effects of Resveratrol: a Review.

Authors:  Marcos Roberto de Oliveira; Aline Lukasievicz Chenet; Adriane Ribeiro Duarte; Giselli Scaini; João Quevedo
Journal:  Mol Neurobiol       Date:  2017-07-10       Impact factor: 5.590

4.  Acute and chronic treatment with quetiapine induces antidepressant-like behavior and exerts antioxidant effects in the rat brain.

Authors:  Zuleide M Ignácio; Gislaine Z Réus; Helena M Abelaira; Airam B de Moura; Thays G de Souza; Danyela Matos; Mariana P Goldim; Khiany Mathias; Leandro Garbossa; Fabricia Petronilho; João Quevedo
Journal:  Metab Brain Dis       Date:  2017-05-06       Impact factor: 3.584

Review 5.  The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology.

Authors:  Emily L Belleau; Michael T Treadway; Diego A Pizzagalli
Journal:  Biol Psychiatry       Date:  2018-10-10       Impact factor: 13.382

6.  The effects of exercise on oxidative stress (TBARS) and BDNF in severely depressed inpatients.

Authors:  Felipe Barreto Schuch; Mirela Paiva Vasconcelos-Moreno; Carolina Borowsky; Ana Beatriz Zimmermann; Bianca Wollenhaupt-Aguiar; Pamela Ferrari; Marcelo Pio de Almeida Fleck
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-02-01       Impact factor: 5.270

7.  Biobehavioral and neuroendocrine correlates of antioxidant enzyme activity in ovarian carcinoma.

Authors:  Jennifer L Bayer; Douglas R Spitz; Desire Christensen; Michael L McCormick; Donna Farley; Koen DeGeest; Laila Damoush; Samantha Aust; Anil K Sood; Susan K Lutgendorf
Journal:  Brain Behav Immun       Date:  2015-05-16       Impact factor: 7.217

8.  Impact of depressive symptoms on oxidative stress in patients with psoriasis.

Authors:  Fatih Karababa; Yavuz Yesilova; Enver Turan; Salih Selek; Hacer Altun; Sahabettin Selek
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

9.  Antidepressant-like effect of celecoxib piroxicam in rat models of depression.

Authors:  Ronise M Santiago; Janaína Barbiero; Bruno J Martynhak; Suelen L Boschen; Luisa M da Silva; Maria F P Werner; Claudio Da Cunha; Roberto Andreatini; Marcelo M S Lima; Maria A B F Vital
Journal:  J Neural Transm (Vienna)       Date:  2014-01-24       Impact factor: 3.575

10.  The Omega-3 Index Is Inversely Associated with Depressive Symptoms among Individuals with Elevated Oxidative Stress Biomarkers.

Authors:  Sherman J Bigornia; William S Harris; Luis M Falcón; José M Ordovás; Chao-Qiang Lai; Katherine L Tucker
Journal:  J Nutr       Date:  2016-03-02       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.